Tarsus (TARS) Director Wendy Yarno Receives 302 Shares (RSU Settlement)

What Happened

• Wendy L. Yarno, a non‑employee director of Tarsus Pharmaceuticals (TARS), had 302 restricted stock units (RSUs vest) converted into 302 shares on 2026-09-15 (reported as a derivative conversion, code M). The filing shows 302 shares were both acquired (issued on settlement) and disposed at $0.00 on the same date.
• No cash proceeds are reported for the disposition (disposed price $0.00), and the filing’s footnotes state the shares were issued pursuant to settlement of vested RSUs granted for her service as a non‑employee director.

Key Details

• Transaction date: 2026-09-15; Form 4 filed: 2026-09-17 (timely, within the two-business‑day reporting window).
• Shares involved: 302 shares issued on RSU settlement; 302 shares reported disposed at $0.00.
• Footnotes: F1–F3 confirm these were vested RSUs (each RSU = one share) and describe the grant and vesting schedule (vests in equal installments on 9/15/2026, 12/15/2026, 3/15/2027 and 6/15/2027).
• Shares owned after the transaction: not specified in this filing.
• Filing indicates conversion/settlement of RSUs (derivative conversion). The filing does not specify the reason for the $0.00 disposition (the form does not state whether shares were withheld for taxes or otherwise transferred).

Context

• This was an RSU vest/settlement for a director — not an open‑market buy or sale. Such settlements are routine compensation events and do not, by themselves, indicate a buy/sell signal.
• For derivative/code M entries: this means a derivative security (here RSUs) converted into common shares. The simultaneous $0.00 disposition simply indicates no reported sale proceeds in the filing; the exact mechanics (e.g., share withholding for taxes) are not detailed.